Actinium Pharmaceuticals Initiates Pursuit of Scientific Advice for Iomab-B from the European Medicines Agency Oct 25, 2016
Actinium Announces Acceptance of Actimab-A Data for Poster Presentation at American Society of Hematology Annual Meeting Oct 19, 2016
Actinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Iomab-B Oct 18, 2016
Actinium Announces Initiation of Phase 2 Clinical Trial of Actimab-A in Patients Newly Diagnosed with Acute Myeloid Leukemia Over Age 60 Sep 27, 2016
Actinium Pharmaceuticals to Sponsor and Participate in Be The Match® Walk+Run to Raise Awareness for Bone Marrow Transplant Sep 26, 2016
Actinium Pharmaceuticals to Host Webinar to Provide Update on Actimab-A Phase 2 Clinical Trial Sep 21, 2016
Actinium Pharmaceuticals Selects Vector Oncology as its Clinical Research Organization for Actimab-A Phase 2 Trial Sep 20, 2016